Rocuronium Fresenius rocuronium bromide 50mg/5mL solution for injection vial

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
26-11-2017

Toimeaine:

rocuronium bromide, Quantity: 10 g/L

Saadav alates:

Fresenius Kabi Australia Pty Ltd

INN (Rahvusvaheline Nimetus):

Rocuronium bromide

Ravimvorm:

Injection, solution

Koostis:

Excipient Ingredients: water for injections; glacial acetic acid; sodium acetate trihydrate; sodium chloride

Manustamisviis:

Intravenous

Ühikuid pakis:

10 x 5mL, 5 x 5mL

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

INDICATIONS,Rocuronium is indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.,Rocuronium is also indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children.,Rocuronium is also indicated as an adjunct in the intensive care unit (ICU) to facilitate mechanical ventilation.

Toote kokkuvõte:

Visual Identification: A clear, colourless to pale brownish-yellow solution.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2014-11-12